Self-Assembly of Amyloid Fibrils into 3D Gel Clusters versus 2D Sheets

Biomolecules. 2023 Jan 24;13(2):230. doi: 10.3390/biom13020230.

Abstract

The deposition of dense fibril plaques represents the pathological hallmark for a multitude of human disorders, including many neurodegenerative diseases. Fibril plaques are predominately composed of amyloid fibrils, characterized by their underlying cross beta-sheet architecture. Research into the mechanisms of amyloid formation has mostly focused on characterizing and modeling the growth of individual fibrils and associated oligomers from their monomeric precursors. Much less is known about the mechanisms causing individual fibrils to assemble into ordered fibrillar suprastructures. Elucidating the mechanisms regulating this "secondary" self-assembly into distinct suprastructures is important for understanding how individual protein fibrils form the prominent macroscopic plaques observed in disease. Whether and how amyloid fibrils assemble into either 2D or 3D supramolecular structures also relates to ongoing efforts on using amyloid fibrils as substrates or scaffolds for self-assembling functional biomaterials. Here, we investigated the conditions under which preformed amyloid fibrils of a lysozyme assemble into larger superstructures as a function of charge screening or pH. Fibrils either assembled into three-dimensional gel clusters or two-dimensional fibril sheets. The latter displayed optical birefringence, diagnostic of amyloid plaques. We presume that pH and salt modulate fibril charge repulsion, which allows anisotropic fibril-fibril attraction to emerge and drive the transition from 3D to 2D fibril self-assembly.

Keywords: amyloid fibril; gelation; hen egg-white lysozyme; plaque formation; self-assembly.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amyloid beta-Peptides / chemistry
  • Amyloid* / chemistry
  • Amyloidogenic Proteins
  • Humans
  • Neurodegenerative Diseases*
  • Sodium Chloride

Substances

  • Amyloid
  • Amyloidogenic Proteins
  • Sodium Chloride
  • Amyloid beta-Peptides

Grants and funding

This research was supported, in part, by NSF REU fellowships (DMR-1852269) to L. Tirado and O. Williams.